SpringRock Ventures

Active

Overview

SpringRock Ventures is a venture capital firm based in Seattle, Washington, investing in the convergence of healthcare and information technology. It targets early to late-stage companies in digital health, devices, SaaS, oral health, wellness, and related disruptive sectors, with investments ranging from $2 million to $5 million per company across North America.¹²³

History

SpringRock Ventures was founded in 2015 by Managing Directors Eric Bell and Kirsten Morbeck, who bring experience from investing in over 40 venture-backed companies with more than 25 IPOs and acquisitions.¹³⁴ The firm focuses on healthcare innovation including SaaS, devices, services, and genomics.¹² It maintains an active presence with one fund in market as of March 2024 and a closed fund from July 2020.⁴

Notable Products

Cyrus Biotechnology - Portfolio investment in biotechnology.
CSATS - Portfolio investment acquired by Johnson & Johnson.
Carrum Health - Portfolio investment in healthcare services.

Reputation

SpringRock Ventures is recognized for its experienced team with proven track records in healthcare and technology investments, including successful exits creating significant market value.¹² Professionals note its focus on disruptive healthcare innovators and North American investments.³⁴ Limited public commentary exists on criticisms, with perception tied to its small team size and specialized sector expertise.²

Sources (6)